Lars Ulrik Wahlberg
Chief Executive Officer at NsGene, Inc.
Profile
Lars Ulrik Wahlberg is the founder of NsGene A, which was founded in 1999.
He held the title of Chief Operating Officer & EVP from 2009 to 2010.
Dr. Wahlberg also worked as a Director-Core Technology at CytoTherapuetics, Inc. Dr. Wahlberg holds a doctorate degree from Brown University, Karolinska Institutet, and The University of Texas Medical School At Houston.
Lars Ulrik Wahlberg active positions
| Companies | Position | Start |
|---|---|---|
NsGene, Inc.
 NsGene, Inc. BiotechnologyHealth Technology NsGene, Inc. is an American clinical stage biotechnology company that develops cell encapsulation therapies. The private company was founded by Lars Ulrik Wahlberg, who has been the CEO since incorporation. | Chief Executive Officer | - |
Former positions of Lars Ulrik Wahlberg
| Companies | Position | End |
|---|---|---|
| CytoTherapuetics, Inc. | Corporate Officer/Principal | - |
NsGene A/S
 NsGene A/S Pharmaceuticals: MajorHealth Technology NsGene A/S identifies neurotrophic proteins with therapeutic effects in the nervous system. It is a biotechnology company that focuses primarily on neurodegenerative disorders. The firm provides technologies that target protein therapeutics across the blood-brain-barrier and directly to diseased nerve cells. It develops therapeutic products for multiple indications with high medical needs including Alzheimer’s disease, Parkinson's disease, deafness, neuropathic pain, epilepsy, cortico-basal degeneration, and Huntington’s disease. The company was founded by Lars Ulrik Wahlberg and Teit Eliot Johansen in 1999 and is headquartered in Ballerup, Denmark. | Founder | - |
Training of Lars Ulrik Wahlberg
| Brown University | Doctorate Degree |
| Karolinska Institutet | Doctorate Degree |
| The University of Texas Medical School At Houston | Doctorate Degree |
Experiences
Positions held
Linked companies
| Private companies | 3 |
|---|---|
| CytoTherapuetics, Inc. | Finance |
NsGene A/S
NsGene A/S Pharmaceuticals: MajorHealth Technology NsGene A/S identifies neurotrophic proteins with therapeutic effects in the nervous system. It is a biotechnology company that focuses primarily on neurodegenerative disorders. The firm provides technologies that target protein therapeutics across the blood-brain-barrier and directly to diseased nerve cells. It develops therapeutic products for multiple indications with high medical needs including Alzheimer’s disease, Parkinson's disease, deafness, neuropathic pain, epilepsy, cortico-basal degeneration, and Huntington’s disease. The company was founded by Lars Ulrik Wahlberg and Teit Eliot Johansen in 1999 and is headquartered in Ballerup, Denmark. | Health Technology |
NsGene, Inc.
NsGene, Inc. BiotechnologyHealth Technology NsGene, Inc. is an American clinical stage biotechnology company that develops cell encapsulation therapies. The private company was founded by Lars Ulrik Wahlberg, who has been the CEO since incorporation. | Health Technology |
- Stock Market
- Insiders
- Lars Ulrik Wahlberg
